Clinical Trials Logo

Keratoconus clinical trials

View clinical trials related to Keratoconus.

Filter by:

NCT ID: NCT03760432 Recruiting - Keratoconus Clinical Trials

Collagen Cross-linking in Keratoconus

Start date: June 20, 2018
Phase: N/A
Study type: Interventional

Optical Coherence Tomography (OCT) devices are non-contact instruments that can measure the depth of scars, other causes of cloudiness of the cornea, and degree of corneal thinning in patients with keratoconus. Laser Custom Corneal Collagen Cross-linking (CXL) significantly decreases corneal aberrations and improves vision. This study will use OCT-guided setting for the lasers used in the corneal smoothing portion of the laser custom CXL procedure to assess the affect on visual outcomes.

NCT ID: NCT03753009 Completed - Keratoconus Clinical Trials

Iontophoretic Transepithelial Collagen Cross-linking Versus Epithelium-off Collagen Cross-linking in Pediatric Patients. Three Year Follow up.

Start date: January 1, 2013
Phase:
Study type: Observational

To compare 3 year iontophoretic transepithelial corneal cross-linking (I-ON CXL) outcomes with epithelium-off collagen cross-linking (epi-off CXL)in pediatric patients.

NCT ID: NCT03732599 Enrolling by invitation - Keratoconus Clinical Trials

Comparison Between Standard Deep Anterior Lamellar Keratoplasty (S-DALK) and Intralase Enabled Deep Anterior Lamellar Keratoplaty (IE-DALK)

Start date: April 8, 2015
Phase: N/A
Study type: Interventional

A prospective comparison between standard deep anterior lamellar keratoplasty (S-DALK) performed manually using a blade (trephine) and femtosecond laser-enabled deep anterior lamellar keratoplasty (IE DALK), where incisions are performed using the femtosecond laser.

NCT ID: NCT03661164 Completed - Keratoconus Clinical Trials

Iontophoretic Transepithelial Corneal Cross-linking in Pediatric Patients

Start date: May 1, 2013
Phase:
Study type: Observational

To report three year follow up in pediatric patients with keratoconus after iontophoretic transepithelial corneal cross-linking (CXL) to assess preoperative factors that may influence ectasia progression

NCT ID: NCT03647046 Completed - Keratoconus Clinical Trials

Custom Anterior Surfacing of Scleral Lens for Vision Quality Improvement in Patients With Keratoconus

Start date: October 8, 2018
Phase: N/A
Study type: Interventional

The goal of the study is to examine the effects of custom front-surface wavefront correction on visual performance, and on neutralization of higher order aberrations, in patients wearing a scleral lens device. The investigators will study patients with keratoconus, the most common type of corneal ectasia, who have already been fitted with the BostonSight BSS (Boston Sight Scleral) for improved visual function.

NCT ID: NCT03637673 Recruiting - Keratoconus Clinical Trials

The Possible Role of Thyroxine in Keratoconus Development

Start date: June 1, 2018
Phase:
Study type: Observational

Keratoconus (KC) is a corneal ectatic disorders, with incidence rate 1 per 50,000 among the population. Hormonal imbalances may be associated with KC as it affects the corneal metabolism. In this study, we aim to examine this clinical association between thyroid gland dysfunction (TGD) and KC.

NCT ID: NCT03619434 Recruiting - Keratoconus Clinical Trials

Femtolaser Assisted Keratoplasty Versus Conventional Keratoplasty

Start date: February 1, 2019
Phase: N/A
Study type: Interventional

This pilot study will compare upto 15 patients undergoing femtolaser assisted keratoplasty (using CE[Conformité Européene] approved femtolaser apparatus) with upto 15 patients undergoing conventional keratoplasty with a manual trephine. Patients will be randomly assigned to either group. All keratoplasties will be penetrating keratoplasties. The following aims of this research is detailed below: 1. Does femtosecond laser assisted keratoplasty ( FLAK ) yield faster visual recovery and better long term BCVA (Best Corrected Visual Acuity)? 2. Does FLAK offer a biomechanically stronger cornea and thereby more safety and less risk of wound dehiscence? 3. Is there any difference between FLAK and conventional keratoplasty in terms of graft failure or rejection? Follow up in best corrected visual acuity, various refraction/astigmatism measurements, intraocular pressure, graft rejection/failure rates, pachymetry and corneal hysteresis and resistance factor will be recorded at 1 day, 1 week, 1, 3 and 6 months and 1 year and 18 months postoperatively. This study, to the investigators' knowledge will be the first randomised controlled trial in this area, the first to provide an empirical measurement to biomechanical stability of the cornea with the femtolaser, and the first done in an NHS (National Health Service) setting.

NCT ID: NCT03598634 Completed - Keratoconus Clinical Trials

Epi Off Versus Epi on Corneal Collagen Cross-linking in Keratoconus Patients

Start date: June 1, 2014
Phase: N/A
Study type: Interventional

To evaluate two different techniques of cross linking: standard epithelium off (CXL epi off) versus trans-epithelial (CXL epi on) cross linking in patient with progressive keratoconus.

NCT ID: NCT03584243 Active, not recruiting - Keratoconus Clinical Trials

Transepithelial Corneal Collagen Crosslinking in Eyes With Progressive Keratoconus

TE-CXL
Start date: December 21, 2017
Phase: N/A
Study type: Interventional

Keratoconus is a corneal ectatic disease responsible for a loss of visual acuity when the steepening increases. Corneal collagen crosslinking (CXL) is a procedure that appears to halt or slow down the progression and avoid the visual impairment. However, such a technique requires the epithelium debridement, wich can be responsible for severs complications. This study evaluate the safety and efficacy of transepithelial corneal crosslinking with oxygen to halt or slow down the progression of keratoconus. Such a procedure avoids the epithelium debridement and the related complications.

NCT ID: NCT03560609 Recruiting - Glaucoma Clinical Trials

Optic Nerve Head Structural Response to IOP Elevation in Patients With Keratoconus

Start date: November 15, 2018
Phase: N/A
Study type: Interventional

The mechanism by which vision loss in glaucoma occurs is still unknown, but it is clear that increased Intraocular Pressure (IOP) is a major risk factor. It is also thought that the lamina cribrosa (LC) is a site of primary damage during the pathogenesis of the disease. The changes caused by intraocular pressure (IOP) modulation at the level of the optic nerve head and LC will be evaluated in the present study. Subjects with keratoconus exhibit abnormal collagen properties that can impair their LC behavior. By evaluating their lamina biomechanical response we can advance our understanding on the role of the lamina in glaucoma pathogenesis. A better understanding of the process will ultimately lead to improved detection and management of glaucoma. It is hypothesized that subjects with keratoconus have an abnormal biomechanical response of the lamina cribrosa in response to IOP modulation.